Ella R, Vadrevu KM, Jogdand H, Prasad S, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis 2021 Jan 21. pii: S1473-3099(20)30942.
PMID: 33485468